The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2017

Filed:

Sep. 23, 2014
Applicant:

Glycovaxyn Ag, Schlieren, CH;

Inventors:

Michael Wacker, Unterengstringen, CH;

Michael Kowarik, Zurich, CH;

Michael Wetter, Zurich, CH;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/085 (2006.01); C12N 15/70 (2006.01); C12N 15/74 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/085 (2013.01); C12N 15/70 (2013.01); C12N 15/74 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6087 (2013.01); A61K 2039/64 (2013.01); C07K 2319/034 (2013.01);
Abstract

The present invention encompasses a novelbioconjugate vaccine. More generally, the invention is directed to Gram-positive and other bioconjugate vaccines containing a protein carrier, at least one polysaccharide such as a capsular Gram-positive polysaccharide, and, optionally, an adjuvant or pharmaceutically acceptable carrier. The instant invention also includes methods of producing Gram-positive and other bioconjugate vaccines. An N-glycosylated protein is also provided that contains one or more polysaccharides such as Gram-positive polysaccharides. The invention is additionally directed to engineered prokaryotic organisms comprising nucleotide sequences encoding a glycosyltransferase of a first prokaryotic organism and a glycosyltransferase of a second prokaryotic organism. The invention further includes plasmids and prokaryotic cells transformed with plasmids encoding polysaccharides and enzymes which produce an N-glycosylated protein and/or bioconjugate vaccine. Further, the invention is directed to methods of inducing an immune response in a mammal comprising administering said bioconjugate vaccines.


Find Patent Forward Citations

Loading…